RNXT Insider Trading Activity and SEC Form 4 Filings
RNXT insider trading summary
Over the past 12 months, insiders at RenovoRx, Inc. (RNXT) reported 12 open-market purchases worth $76K by 4 insiders and no sales on SEC Form 4. Net insider buying was $76K.
Latest RNXT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 19, 2026 | Mark Voll | Chief Financial Officer | Buy | $20K (25,000 @ $0.79) |
| Mar 20, 2026 | Mark Voll | Chief Financial Officer | Buy | $0 (97,200 @ $0.00) |
| Mar 20, 2026 | Laurence Marton | Director | Buy | $0 (9,720 @ $0.00) |
| Mar 20, 2026 | Shaun Bagai | Chief Executive Officer | Buy | $0 (24,300 @ $0.00) |
| Jan 21, 2026 | Ramtin Agah | Chief Medical Officer | Buy | $10K (10,000 @ $1.00) |
| Dec 30, 2025 | Ramtin Agah | Chief Medical Officer | Buy | $169 (205 @ $0.83) |
| Dec 18, 2025 | Shaun Bagai | Chief Executive Officer | Buy | $5K (5,000 @ $0.90) |
| Dec 17, 2025 | Shaun Bagai | Chief Executive Officer | Buy | $4K (5,000 @ $0.85) |
| Dec 16, 2025 | Ramtin Agah | Chief Medical Officer | Buy | $10K (12,000 @ $0.85) |
| Dec 5, 2025 | Ramtin Agah | Chief Medical Officer | Buy | $10K (10,000 @ $0.96) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.